Davy Research

ICON (ICLR.O, ICLR US)

  • 6171.7
  • 54.2
  • 98.1

Company Profile

ICON plc is a full-service clinical research organisation (CRO) that provides a comprehensive range of clinical services in Phase I-IV clinical trials to the pharmaceutical, biotechnology and device industries. These services include clinical research, biometrics, interactive technologies, laboratory, clinical pharmacology and consulting services. They are offered on a global basis to clients from 69 locations in 39 countries worldwide.


Major Shareholders%
Neuberger Berman LLC 9.8
EARNEST Partners 9.0
AllianceBernstein 4.8
Wasatch Advisors Inc 4.7
  • ICON

    Closing Price (c): 11397.0

  • RATING 01/05/14

  • PREVIOUS RATING 27/10/11

    NEUTRAL

Analyst(S)

COMPANY DATA

UPCOMING EVENTS

  • There are no upcomming events at present